Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

28 October 2020: Lab/In Vitro Research

Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells

Jing Gong 1ABCDEF* , Yongxi Song 2AB* , Ling Xu 3ACEF , Xiaofang Che 3DEF , Kezuo Hou 3BC , Tianshu Guo 3BC , Yu Cheng 3ABG , Yunpeng Liu 3ADE* , Xiujuan Qu 3AG*

DOI: 10.12659/MSM.927411

Med Sci Monit 2020; 26:e927411

Figure 6 Representative images for CXCR4 and SERPINB3 immunohistochemical staining in gastric cancer tissues along with overall survival. (A) H&E staining of GC tissue, with negative control and positive expression shown by immunohistochemistry (×200). CXCR4-positive staining was observed in the cell membrane and cytoplasm (in brown). SERPINB3-positive staining was observed in cell nuclei and cytoplasm (in brown). (B) Overall survival (OS) of SERPINB3-positive or SERPINB3-negative patients with gastric cancer was estimated by the Kaplan-Meier method and log-rank test (n=96, P<0.05). (C) OS of CXCR4-positive or CXCR4-negative patients with gastric cancer was estimated by the Kaplan-Meier method and log-rank test (n=96, P=0.036). (D) OS of CXCR4-positive and SERPINB3-positive patients with gastric cancer was estimated by the Kaplan-Meier method and log-rank test (n=96, P<0.05). (E) Among the CXCR4-positive patients, the OS of SERPINB3-positive patients was estimated by the Kaplan-Meier method and log-rank test (P<0.001). (F) Among the CXCR4-negative patients, the OS of SERPINB3-positive patients was estimated by the Kaplan-Meier method and log-rank test (P=0.102).

  • Download PDF
  • Order reprints
  • Export Article
  • Related articles
  • Share by email
  • Metrics

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750